EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine

Adeboye O Bamgboye, Lisa D Coles, Bovornpat Suriyapakorn, Usha Mishra, Robert L Kriel, Ilo E Leppik, James R White, James C Cloyd

The Journal of Clinical Pharmacology · 2026-04 · 66 (4)

DOI: 10.1002/jcph.70191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 16.04.2026. Verfasst von Adeboye O Bamgboye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Epilepsy, Fructose, Migraine Disorders, Anticonvulsants. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topiramate (TPM) is approved for seizures and migraine prophylaxis and is used off‐label for several neuropsychiatric conditions. The available dosage forms, including tablets and sprinkle capsules, are unsuitable for patients who may be unable to take medicine orally. The resulting potential treatment interruption could have untoward consequences and underscore the importance of developing a parenteral formulation. In this study, we developed a population pharmacokinetic model of a novel intravenous TPM formulation using data from a study in patients with epilepsy or migraine who received a single intravenous dose of stable‐isotope‐labeled TPM. In total, 246 TPM concentrations from 20 adult patients were included for model development. A three‐compartment pharmacokinetic model with linear elimination fit the concentration–time data best. Simulations for various loading doses in patients with and without enzyme‐inducing comedications were performed. The final estimates (95% confidence interval [CI]) for CL (L/h), V1 (L), and the peripheral volumes, V2 and V3, for a 70 kg person were 1.31 (1.01–1.53), 9.84 (8.49–11.0), 39.1 (36.5–41.8), and 9.01 (6.41–44.3), respectively. The use of enzyme‐inducing co‐medication was the only significant covariate, associated with a 63% increase in clearance. Goodness‐of‐fit plots and visual predictive checks indicate satisfactory model performance and prediction. Pharmacokinetic simulations indicated that IV TPM loading doses do not require adjustment when used as a replacement for interrupted oral therapy. This population pharmacokinetic model for intravenous topiramate can inform dosing decisions for patients with epilepsy when used as either initiation or bridging therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyFructoseMigraine DisordersAnticonvulsantsModels, BiologicalHumansTopiramateAdultFemaleMaleMiddle AgedYoung AdultAdministration, IntravenousAdolescent

Stichwörter der Autor:innen

enzyme inducersepilepsymigrainepopulation pharmacokineticstopiramate

Substanzen

TopiramateFructoseAnticonvulsants

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
  • Department of Neurology, University of Minnesota, Minneapolis, MN, USA.
  • Minnesota Epilepsy Group, University of Minnesota, Roseville, MN, USA.

Zitieren

APA

Bamgboye, A. O., Coles, L. D., Suriyapakorn, B., Mishra, U., Kriel, R. L., Leppik, I. E., White, J. R., & Cloyd, J. C. (2026). Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine. The Journal of Clinical Pharmacology, 66(4). https://doi.org/10.1002/jcph.70191

Vancouver

Bamgboye AO, Coles LD, Suriyapakorn B, Mishra U, Kriel RL, Leppik IE, et al. Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine. The Journal of Clinical Pharmacology. 2026;66(4). doi:10.1002/jcph.70191

BibTeX
@article{Bamgboye2026,
  author = {Bamgboye, Adeboye O and Coles, Lisa D and Suriyapakorn, Bovornpat and Mishra, Usha and Kriel, Robert L and Leppik, Ilo E and White, James R and Cloyd, James C},
  title = {Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine},
  journal = {The Journal of Clinical Pharmacology},
  year = {2026},
  volume = {66},
  number = {4},
  doi = {10.1002/jcph.70191}
}
Kostenlos starten →